Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7728-7737
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Table 1 Clinical characteristics
Characteristics | Number (n) | Percent (%) |
Median age (yr) | 59 | |
Age range (yr) | 26-82 | |
Sex | ||
Male | 33 | 54 |
Female | 28 | 46 |
Treatment area | ||
Head and neck | 12 | 20 |
Chest | 13 | 21 |
Abdomen | 10 | 16 |
Pelvic | 14 | 23 |
Spine and bone | 12 | 20 |
Treatment type | ||
Primary tumour | 34 | 56 |
Recurrence in situ | 1 | 1 |
Metastasis | 26 | 43 |
Radiation technology | ||
IMRT | 21 | 35 |
VMAT | 39 | 64 |
SRT | 1 | 1 |
Concurrent therapy | ||
Chemotherapy | 15 | |
Other1 | 15 | |
No | 31 | |
Radiation toxicities | ||
No | 23 | 38 |
Cured after treatment | 34 | 56 |
Yes | 4 | 6 |
- Citation: Wang GY, Zhu QZ, Zhu HL, Jiang LJ, Zhao N, Liu ZK, Zhang FQ. Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study. World J Clin Cases 2022; 10(22): 7728-7737
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7728.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7728